LSM3, NDUFB3, and PTGS2 may be potential biomarkers for BRCA1-mutation positive breast cancer

Affiliations

Hu Kang: Breast and Thyroid Disease Medical Center, Affiliated Hospital of Zunyi Medical University, Zunyi, GuiZhou province, 563003, China
Gan Fengjiao: Breast and Thyroid Disease Medical Center, Affiliated Hospital of Zunyi Medical University, Zunyi, GuiZhou province, 563003, China
Wang Xue: Breast and Thyroid Disease Medical Center, Affiliated Hospital of Zunyi Medical University, Zunyi, GuiZhou province, 563003, China
Xu Lin: Department of Oncology Laboratory, Affiliated Hospital of Zunyi Medical University, Zunyi, GuiZhou province, 563003, China
Wu Qiaoyuan: Department of Oncology Laboratory, Affiliated Hospital of Zunyi Medical University, Zunyi, GuiZhou province, 563003, China
Jiang Ni: Department of Oncology Laboratory, Affiliated Hospital of Zunyi Medical University, Zunyi, GuiZhou province, 563003, China
Sun Suhong: Breast and Thyroid Disease Medical Center, Affiliated Hospital of Zunyi Medical University, Zunyi, GuiZhou province, 563003, China

Abstract

Purpose: We aimed to find critical biomakers associated with BRCA1-mutation positive breast cancer.